8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)   July 26, 2005

ENCISION, INC.

(Exact name of registrant as specified in its charter)

Colorado	0-28604	84-1162056
(State or other jurisdiction  of incorporation)	(Commission  File Number)	(I.R.S. Employer Identification No.)
6797 Winchester Circle, Boulder, Colorado		80301
(Address of principal executive offices)		(Zip Code)
Registrant’s telephone number, including area code  (303) 444-2600
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02 Results of Operations and Financial Condition

                   The following information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition,” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section.

                    On July 26, 2005, ENCISION, INC., issued a press release announcing its financial results for the first quarter ended June 30, 2005.  A copy of the press release is attached hereto as Exhibit 99.1.

                    The information contained in this Current Report, including the exhibit, shall not be incorporated by reference into any filing of ENCISION, INC., whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.

(c)          Exhibits.

99.1 Press Release issued by ENCISION, INC., July 26, 2005.

SIGNATURES

          Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ENCISION, INC.
	(Registrant)
Date July 26, 2005
	/s/ MARCIA K. MCHAFFIE
	Marcia K. McHaffie
	Controller
	Principal Accounting Officer

EX-99.1

Exhibit 99.1

Encision Reports First Fiscal Quarter Revenue Increases 30%

          BOULDER, Colo., July 26 /PRNewswire-FirstCall/ -- Encision Inc.(Amex: ECI), a medical device company with patented surgical technology emerging as a standard of care in minimally-invasive surgery, reported its financial results for its first fiscal quarter ended June 30, 2005.    Revenue for the first fiscal quarter ended June 30, 2005 of $2,289,000represented a 30 percent increase over prior fiscal year’s first fiscal quarter revenue of $1,763,000.  Net income of $19,000 or $.00 per share for the first fiscal quarter compares to a net loss of $(291,000) or $(.05) per share for last year’s first fiscal quarter.  Last year’s first quarter included a one-time expense of approximately $201,000 (including attorney and arbitrator fees) for resolution of an arbitration dispute with one of Encision’s distributors.  Gross Profit Margin for the first quarter of fiscal year 2006 was 60 percent as compared to 58 percent for the first quarter of fiscal year 2005.

           “I am pleased with our results for the first quarter,” said Jack Serino,President and CEO of Encision.  “Initiatives that we began in fiscal year 2005of substantial investments in our quality systems, product development and distribution were intended to increase customer satisfaction and retention while pursuing a more direct sales focus.  These initiatives are beginning to produce positive results.”

          Encision Inc. designs and manufactures innovative surgical devices that allow the surgeon to optimize technique and patient safety during a broad range of surgical procedures.  Based in Boulder, Colorado, the Company pioneered the development of patented AEM(R) Laparoscopic Instruments to improve electro surgery and reduce the chance for patient injury in minimally invasive surgery.

          In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the Company notes that statements in this press release and elsewhere that look forward in time, which include everything other than historical information, involve risks and uncertainties that may cause actual results to differ materially from those indicated by the forward-looking statements.  Factors that could cause the Company’s actual results to differ materially include, among others, its ability to increase revenues through the Company’s distribution channels, insufficient quantity of new account conversions, insufficient cash to fund operations, scale up production to meet delivery obligations, delay in developing new products and receiving FDA approval for such new products and other factors discussed in the Company’s filings with the Securities and Exchange Commission.

          CONTACT:  Marcia McHaffie, Encision Inc., 303-444-2600, mmchaffie@encision.com

ENCISION INC.
Results of Operations
(Unaudited)

	Three Months Ended June 30,
	2005			2004
Net Revenue	$	2,289,000		$	1,763,000
Cost of Revenue		904,000			747,000
Gross Profit		1,385,000			1,016,000
Gross Margin		60.5	%		57.6	%
Operating Expenses		1,371,000			1,307,000
Operating Income (Loss)		14,000			(291,000	)
Net Income (Loss)	$	19,000		$	(291,000	)
Net Income (Loss) per Share	$	.00		$	(.05	)

ENCISION INC.
Condensed Balance Sheets
(Unaudited)

	June 30,		June 30,
	2005		2004
Cash and Cash Equivalents	$	1,115,000	$	1,409,000
Current Assets		3,756,000		3,531,000
Total Assets		4,278,000		3,979,000
Current Liabilities		1,210,000		1,145,000
Shareholders’ Equity		3,068,000		2,823,000
Total Liabilities and Shareholders’ Equity	$	4,278,000	$	3,979,000

SOURCE  Encision Inc.
    - -0-                             07/26/2005
    /CONTACT:  Marcia McHaffie of Encision Inc., +1-303-444-2600, mmchaffie@encision.com/
    /Web site:  http://www.encision.com /

_